| Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055) (NCT01014013) | Merck Sharp & Dohme LLC | 2008-04-01 |
| Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003) (NCT00610441) | Merck Sharp & Dohme LLC | 2008-04-01 |
| Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001) (NCT00543387) | Merck Sharp & Dohme LLC | 2008-03-27 |
| Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019) (NCT00685776) | Merck Sharp & Dohme LLC | 2008-03-24 |
| A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) (NCT00654420) | Merck Sharp & Dohme LLC | 2008-03-19 |
| Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034) (NCT00662818) | Merck Sharp & Dohme LLC | 2008-03-17 |
| A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002) (NCT00631657) | Merck Sharp & Dohme LLC | 2008-03-04 |
| Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) (NCT00632203) | Merck Sharp & Dohme LLC | 2008-03-04 |
| An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED) (NCT00642798) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241) (NCT00632073) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) (NCT00966030) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) (NCT00723827) | Merck Sharp & Dohme LLC | 2008-03-01 |
| A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069) (NCT00835380) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis (NCT00629590) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) (NCT00762983) | Merck Sharp & Dohme LLC | 2008-03-01 |
| V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED) (NCT00735839) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers (NCT00575367) | Merck Sharp & Dohme LLC | 2008-03-01 |
| ALPHA Sitagliptin Add on to Metformin (0431-103) (NCT00833027) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Bioequivalence of Two Tablet Forms of MK0974 (0974-045) (NCT00965887) | Merck Sharp & Dohme LLC | 2008-03-01 |
| A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093) (NCT01104519) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis (NCT00629941) | Merck Sharp & Dohme LLC | 2008-03-01 |
| An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) (NCT00635830) | Merck Sharp & Dohme LLC | 2008-03-01 |
| A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001) (NCT00648648) | Merck Sharp & Dohme LLC | 2008-02-25 |
| A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) (NCT00604188) | Merck Sharp & Dohme LLC | 2008-02-22 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002) (NCT00635804) | Merck Sharp & Dohme LLC | 2008-02-19 |
| Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074) (NCT00642954) | Merck Sharp & Dohme LLC | 2008-02-13 |
| A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) (NCT01294709) | Merck Sharp & Dohme LLC | 2008-02-12 |
| A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED) (NCT01021527) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease (NCT00625612) | Merck Sharp & Dohme LLC | 2008-02-01 |
| A Study of ProQuad™ in Healthy Children in Korea (V221-023) (NCT00839917) | Merck Sharp & Dohme LLC | 2008-02-01 |
| A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) (NCT00617890) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis (NCT00629980) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015) (NCT00620659) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017) (NCT00619359) | Merck Sharp & Dohme LLC | 2008-02-01 |
| GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077) (NCT01355003) | Merck Sharp & Dohme LLC | 2008-02-01 |
| A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015) (NCT00631488) | Merck Sharp & Dohme LLC | 2008-02-01 |
| MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066) (NCT00532935) | Merck Sharp & Dohme LLC | 2008-01-26 |
| A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED) (NCT00541450) | Merck Sharp & Dohme LLC | 2008-01-15 |
| A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) (NCT00561574) | Merck Sharp & Dohme LLC | 2008-01-09 |
| Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080) (NCT00929201) | Merck Sharp & Dohme LLC | 2008-01-01 |
| A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) (NCT00635648) | Merck Sharp & Dohme LLC | 2008-01-01 |
| A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED) (NCT00418613) | Merck Sharp & Dohme LLC | 2008-01-01 |
| A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417) (NCT00741104) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Induced Sputum Study (0000-065) (NCT00623714) | Merck Sharp & Dohme LLC | 2008-01-01 |
| A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED) (NCT00704054) | Merck Sharp & Dohme LLC | 2008-01-01 |
| The Effect of MK0633 in Patients With Chronic Asthma (0633-007) (NCT00404313) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) (NCT00686894) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED) (NCT00686777) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634) (NCT00600288) | Merck Sharp & Dohme LLC | 2008-01-01 |
| A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064) (NCT00816712) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004) (NCT00614393) | Merck Sharp & Dohme LLC | 2007-12-24 |
| Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) (NCT00564421) | Merck Sharp & Dohme LLC | 2007-12-18 |
| A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001) (NCT00559182) | Merck Sharp & Dohme LLC | 2007-12-05 |
| Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) (NCT00620113) | Merck Sharp & Dohme LLC | 2007-12-03 |
| Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (NCT00686686) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209) (NCT00724464) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) (NCT00518687) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers (NCT00564447) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) (NCT00686543) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875) (NCT00551018) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery (NCT00575380) | Merck Sharp & Dohme LLC | 2007-12-01 |
| A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) (NCT00550732) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Neuropathic Pain Syndrome Patient Study (MK-0000-072) (NCT00570310) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) (NCT00527943) | Merck Sharp & Dohme LLC | 2007-12-01 |
| MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016) (NCT00506077) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) (NCT00566527) | Merck Sharp & Dohme LLC | 2007-11-29 |
| Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) (NCT00537017) | Merck Sharp & Dohme LLC | 2007-11-23 |
| A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) (NCT00551213) | Merck Sharp & Dohme LLC | 2007-11-21 |
| Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026) (NCT00701389) | Merck Sharp & Dohme LLC | 2007-11-20 |
| Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) (NCT00561821) | Merck Sharp & Dohme LLC | 2007-11-20 |
| A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002) (NCT00535236) | Merck Sharp & Dohme LLC | 2007-11-02 |
| Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED) (NCT00724373) | Merck Sharp & Dohme LLC | 2007-11-01 |
| Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009) (NCT00567112) | Merck Sharp & Dohme LLC | 2007-11-01 |
| Protocol for Eslax Intravenous Drug Use Investigation (Study P06082) (NCT00902070) | Merck Sharp & Dohme LLC | 2007-11-01 |
| Biomarkers of Muscle Anabolism (MK-0000-082) (NCT00812396) | Merck Sharp & Dohme LLC | 2007-11-01 |
| Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043) (NCT00561080) | Merck Sharp & Dohme LLC | 2007-10-26 |
| Safety Study of ProQuad® rHA in Infants (V221-037) (NCT00560755) | Merck Sharp & Dohme LLC | 2007-10-24 |
| Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) (NCT00509236) | Merck Sharp & Dohme LLC | 2007-10-19 |
| Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) (NCT00509262) | Merck Sharp & Dohme LLC | 2007-10-09 |
| ROTATEQ™ Post-Marketing Surveillance in the Philippines (NCT01357174) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED) (NCT01209741) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6) (NCT00538239) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis (NCT00534794) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005) (NCT00529659) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022) (NCT00534248) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) (NCT00500006) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) (NCT00520598) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) (NCT00686595) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006) (NCT00543413) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095) (NCT00961480) | Merck Sharp & Dohme LLC | 2007-10-01 |
| ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED) (NCT00546819) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED) (NCT00539721) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) (NCT00551187) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED) (NCT00798395) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) (NCT00746694) | Merck Sharp & Dohme LLC | 2007-10-01 |
| GARDASIL Reexamination Study (V501-059) (NCT01062074) | Merck Sharp & Dohme LLC | 2007-09-28 |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) (NCT00543543) | Merck Sharp & Dohme LLC | 2007-09-24 |
| Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001) (NCT00610649) | Merck Sharp & Dohme LLC | 2007-09-20 |
| A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) (NCT00529373) | Merck Sharp & Dohme LLC | 2007-09-13 |
| A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED) (NCT01033318) | Merck Sharp & Dohme LLC | 2007-09-11 |